Exchange: OTC·Updated 12:17 PM EDT

PVCT Provectus Biopharmaceuticals Inc.

$0.0586
$0.001
(1.74%)
Today
Mkt Cap$24.21M
Vol25,919.00

About PVCT

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.
50

Neutral Sentiment

How do you feel about PVCT?

Advertisement|Remove ads.